Home

Management

Michael M. Morrissey, Ph.D.
President and Chief Executive Officer

Scott Garland
Executive Vice President and Chief Commercial Officer

Frank L. Karbe
Executive Vice President and Chief Financial Officer

Peter Lamb, Ph.D.
Executive Vice President, Discovery Research and Chief Scientific Officer

Gisela M. Schwab, M.D.
Executive Vice President and Chief Medical Officer

Pamela A. Simonton, J.D. LL.M.
Executive Vice President, General Counsel

  • About Exelixis
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Strategic Alliances
    • Locations
    • Contact Us
  • Cabozantinib
    • Clinical Trial Information
    • Bone Metastases
    • Preclinical Rationale and Results
    • Frequently Asked Questions
  • Pipeline
    • Cabozantinib (XL184)
    • Out-Licensed Compounds
    • Partnering Compounds
  • Investors
    • Management and Board
    • Corporate Governance
    • Stock Information
    • Analyst Coverage
    • Earnings Estimates
    • Earnings Ratings
    • Annual Reports
    • SEC Filings
    • Press Releases
    • Non-GAAP Financial Measures
    • Event Calendar
    • Information Request
    • Investor FAQs
    • Contact IR
  • Resources
    • Events
    • ASCO 2011 Online Summit
    • CEO Topic
    • Data Presentations
  • Careers
    • Job Opportunities
    • Benefits
    • Events
    • Awards
  • Contact Us

About Exelixis

  • Management
    • Michael M. Morrissey, Ph.D.
    • Scott Garland
    • Frank L. Karbe
    • Peter Lamb, Ph.D.
    • Gisela M. Schwab, M.D.
    • Pamela A. Simonton, J.D., LL.M.
  • Board of Directors
  • Scientific Advisory Board
  • Strategic Alliances
  • Locations
  • Contact Us

© Exelixis, Inc. 2012   Website design: Hane Chow, Inc.
  • Terms of Use